The preclinical discovery and development of opicapone for the treatment of Parkinson’s disease
2020
Opicapone (OPC) is a well-established catechol-O-methyltransferase (COMT) inhibitor that is approved for the treatment of Parkinson’s disease (PD) associated with L-DOPA/L-amino acid decarboxylase ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
63
References
2
Citations
NaN
KQI